Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.66 -0.1 (-2.66%) Market Cap: 1.50 Bil Enterprise Value: 3.90 Bil PE Ratio: 0 PB Ratio: 1.53 GF Score: 59/100

Full Year 2021 Sumitomo Dainippon Pharma Co Ltd Earnings Presentation Transcript

May 13, 2021 / NTS GMT
Release Date Price: €14.5 (+2.11%)

May 13, 2021 / NTS GMT
Presentation
May 13, 2021 / NTS GMT

=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
* Toru Kimura
Sumitomo Dainippon Pharma Co., Ltd. - Executive VP, Chief Scientific Officer & Representative Director

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shohei Oda
Morgan Stanley, Research Division - Research Associate
* Stephen Barker
Jefferies LLC, Research Division - Equity Analyst

=====================
Hiroshi Nomura - Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot